OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comparative Efficacy of Targeted Systemic Therapies for Moderate to Severe Atopic Dermatitis without Topical Corticosteroids: Systematic Review and Network Meta-analysis
Jonathan I. Silverberg, Hwanhee Hong, Jacob P. Thyssen, et al.
Dermatology and Therapy (2022) Vol. 12, Iss. 5, pp. 1181-1196
Open Access | Times Cited: 44
Jonathan I. Silverberg, Hwanhee Hong, Jacob P. Thyssen, et al.
Dermatology and Therapy (2022) Vol. 12, Iss. 5, pp. 1181-1196
Open Access | Times Cited: 44
Showing 26-50 of 44 citing articles:
How to Understand Personalized Medicine in Atopic Dermatitis Nowadays?
Alicja Mesjasz, Karol Kołkowski, Andreas Wollenberg, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7557-7557
Open Access | Times Cited: 4
Alicja Mesjasz, Karol Kołkowski, Andreas Wollenberg, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7557-7557
Open Access | Times Cited: 4
Cost per NNT for upadacitinib in the treatment of patients with moderate-severe atopic dermatitis in Italy
Andrea Chiricozzi, Antonio Costanzo, Anna Levi, et al.
Global & Regional Health Technology Assessment (2024) Vol. 11, Iss. 1, pp. 38-50
Open Access | Times Cited: 1
Andrea Chiricozzi, Antonio Costanzo, Anna Levi, et al.
Global & Regional Health Technology Assessment (2024) Vol. 11, Iss. 1, pp. 38-50
Open Access | Times Cited: 1
Efficacy of Upadacitinib and Dupilumab on Achieving Stringent and Composite Skin and Itch Outcomes: an Indirect Comparison of Adults with Moderate-to-Severe Atopic Dermatitis
April W. Armstrong, Chih-ho Hong, Brian Calimlim, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 9, pp. 2457-2465
Open Access | Times Cited: 1
April W. Armstrong, Chih-ho Hong, Brian Calimlim, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 9, pp. 2457-2465
Open Access | Times Cited: 1
Validation of Diagnoses of Atopic Dermatitis in Hospital Registries: A Cross-sectional Database Study from Finland
Miika Kurki, Suvi‐Päivikki Sinikumpu, Eetu Kiviniemi, et al.
Acta Dermato Venereologica (2023) Vol. 103, pp. adv7266-adv7266
Open Access | Times Cited: 3
Miika Kurki, Suvi‐Päivikki Sinikumpu, Eetu Kiviniemi, et al.
Acta Dermato Venereologica (2023) Vol. 103, pp. adv7266-adv7266
Open Access | Times Cited: 3
Methotrexate therapy for adult and paediatric moderate‐to‐severe atopic dermatitis: A PRISMA‐compliant meta‐analysis of data from daily practice
Qiaohong Wang, Liheng Chen
Australasian Journal of Dermatology (2023) Vol. 65, Iss. 2, pp. 114-127
Closed Access | Times Cited: 2
Qiaohong Wang, Liheng Chen
Australasian Journal of Dermatology (2023) Vol. 65, Iss. 2, pp. 114-127
Closed Access | Times Cited: 2
Atopic Dermatitis and Abrocitinib: Unraveling the Therapeutic Potential
Ayesha Abdul Qadir Memon, Habibun Nisa, Muhammad Osama, et al.
Current Signal Transduction Therapy (2024) Vol. 19, Iss. 2
Closed Access
Ayesha Abdul Qadir Memon, Habibun Nisa, Muhammad Osama, et al.
Current Signal Transduction Therapy (2024) Vol. 19, Iss. 2
Closed Access
Clinical and economic evaluation of tralokinumab for atopic dermatitis
Ryan A. Moreau, Angela Y. Su, Molly M. Csere, et al.
Journal of Managed Care & Specialty Pharmacy (2024) Vol. 30, Iss. 7, pp. 639-645
Closed Access
Ryan A. Moreau, Angela Y. Su, Molly M. Csere, et al.
Journal of Managed Care & Specialty Pharmacy (2024) Vol. 30, Iss. 7, pp. 639-645
Closed Access
Efficacy and Safety of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Meta-Analysis
Bikash Ranjan Meher, Archana Mishra, Biswanath Behera, et al.
Cureus (2024)
Open Access
Bikash Ranjan Meher, Archana Mishra, Biswanath Behera, et al.
Cureus (2024)
Open Access
Budget impact and cost per responder analysis of upadacitinib for the treatment of moderate to severe atopic dermatitis from the perspective of the social security and the private sector in Argentina
Natalia Espínola, Federico Rodríguez Cairoli, Carlos Rojas‐Roque, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2024), pp. 1-11
Closed Access
Natalia Espínola, Federico Rodríguez Cairoli, Carlos Rojas‐Roque, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2024), pp. 1-11
Closed Access
Cost per responder analysis of abrocitinib versus dupilumab in moderate to severe atopic dermatitis
Martina Maurelli, Giampiero Girolomoni, Paolo Gisondi
Italian Journal of Dermatology and Venereology (2024) Vol. 159, Iss. 6
Closed Access
Martina Maurelli, Giampiero Girolomoni, Paolo Gisondi
Italian Journal of Dermatology and Venereology (2024) Vol. 159, Iss. 6
Closed Access
Atopische Dermatitis
Wolf‐Henning Boehncke
DMW - Deutsche Medizinische Wochenschrift (2024) Vol. 149, Iss. 21, pp. 1294-1301
Closed Access
Wolf‐Henning Boehncke
DMW - Deutsche Medizinische Wochenschrift (2024) Vol. 149, Iss. 21, pp. 1294-1301
Closed Access
Systemic Therapy for Atopic Dermatitis in Children and Adolescents: A United States Expert Consensus
Lawrence F. Eichenfield, Mark Boguniewicz, Christine T. Lauren, et al.
Dermatology (2024), pp. 1-13
Open Access
Lawrence F. Eichenfield, Mark Boguniewicz, Christine T. Lauren, et al.
Dermatology (2024), pp. 1-13
Open Access
Macrophages in inflammatory skin diseases and skin tumors
Sihan Liu, Jie Zhang, Ya‐Gang Zuo
Frontiers in Immunology (2024) Vol. 15
Open Access
Sihan Liu, Jie Zhang, Ya‐Gang Zuo
Frontiers in Immunology (2024) Vol. 15
Open Access
Atopic Dermatitis: A Review of Diagnosis and Treatment
Jack Jeskey, Christine Kurien, Henry Blunk, et al.
The Journal of Pediatric Pharmacology and Therapeutics (2024) Vol. 29, Iss. 6, pp. 587-603
Closed Access
Jack Jeskey, Christine Kurien, Henry Blunk, et al.
The Journal of Pediatric Pharmacology and Therapeutics (2024) Vol. 29, Iss. 6, pp. 587-603
Closed Access
New molecules for atopic dermatitis treatment beyond biological therapy
Egídio Freitas, Tiago Torres
Current Opinion in Allergy and Clinical Immunology (2023) Vol. 23, Iss. 3, pp. 210-215
Closed Access | Times Cited: 1
Egídio Freitas, Tiago Torres
Current Opinion in Allergy and Clinical Immunology (2023) Vol. 23, Iss. 3, pp. 210-215
Closed Access | Times Cited: 1
JAK Inhibitor Use for the Inpatient Dermatologist
Eric Xia, Ahana Gaurav, Allison Yan, et al.
Current Dermatology Reports (2023) Vol. 12, Iss. 4, pp. 193-203
Closed Access | Times Cited: 1
Eric Xia, Ahana Gaurav, Allison Yan, et al.
Current Dermatology Reports (2023) Vol. 12, Iss. 4, pp. 193-203
Closed Access | Times Cited: 1
Systemic Treatments for Atopic Dermatitis in Children and Adolescents: Review of Current Practice and New Treatments
Razan Dodein, Alya Abdul‐Wahab, Piu Banerjee
Apollo Medicine (2023) Vol. 20, Iss. 1, pp. 61-70
Open Access
Razan Dodein, Alya Abdul‐Wahab, Piu Banerjee
Apollo Medicine (2023) Vol. 20, Iss. 1, pp. 61-70
Open Access
Pharmacoeconomical analysis of the use of upadacitinib, baricitinib and dupilumab for systemic therapy of patients with moderate and severe atopic dermatitis
S. К. Zyryanov, I. N. Dyakov, N I Ilina
Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice (2023), Iss. 2, pp. 70-84
Open Access
S. К. Zyryanov, I. N. Dyakov, N I Ilina
Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice (2023), Iss. 2, pp. 70-84
Open Access
Resolution of the Working Meeting of Experts in “Dermatology”: Possibilities of systemic therapy of atopic dermatitis with selective immunosuppressants
А. Л. Бакулев, Elena A. Vishnеva, O G Elisyutina, et al.
Russian Journal of Allergy (2022) Vol. 19, Iss. 2, pp. 259-269
Open Access
А. Л. Бакулев, Elena A. Vishnеva, O G Elisyutina, et al.
Russian Journal of Allergy (2022) Vol. 19, Iss. 2, pp. 259-269
Open Access
